Are you suffering from Irritable Bowel Syndrome (IBS)?
IBS affects an estimated 12% of the population in the US and between 10–15% of the population in Europe.
Existing treatments for IBS focus on the management of symptoms; there are currently no available treatments that target the causes of IBS. Current medications for IBS have been associated with several side effects; in a recent Phase 1b clinical study, this investigational medication has been shown to have an increased safety profile and is well tolerated.
Local doctors at Providence Clinical Research are evaluating the effectiveness of an investigational medication in the treatment of people with IBS.
We are looking for men and women who*:
Are aged 18-70 years
Have a diagnosis of IBS
Have moderate to severe IBS symptoms for at least 3 months
*There are other criteria that you will need to meet in order to take part, which the study team will discuss with you.
Investigational medication will be supplied in capsules, which should be taken twice a day 30 minutes before food.
During the study you will be asked to complete questionnaires and a daily diary of your medication intake using a smartphone provided.
To learn more about this study and how you can participate, click on the button below.
By filling out this form, you agree to your information potentially being added to a patient database, along with a study coordinator reaching out to you.